Citation: | WANG Yi, LIU Huilan, QING Bilan, LI Mingfang. Predictive value of serum levels of estrone and estriol for pregnancy outcomes in patients with threatened abortion[J]. Chinese Journal of General Practice, 2024, 22(5): 813-816. doi: 10.16766/j.cnki.issn.1674-4152.003509 |
[1] |
杜黎黎, 蔡璐, 王林. 先兆流产患者保胎后妊娠结局的相关影响因素分析[J]. 中国妇幼保健, 2021, 36(3): 629-631. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202103046.htm
DU L L, CAI L, WANG L. Analysis of related influencing factors of pregnancy outcome in patients with threatened abortion after fetal protection[J]. Maternal and Child Health Care of China, 2021, 36(3): 629-631. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202103046.htm
|
[2] |
张丽, 姜凤华, 关莹莹, 等. 血清HCG、P、E2水平与早期先兆流产中医证型的关系研究[J]. 中华中医药学刊, 2023, 41(4): 221-225. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202304046.htm
ZHANG L, JIANG F H, GUAN Y Y, et al. Relationship between serum HCG, P, E2 and TCM syndrome types of early threatened abortion[J]. Chinese Archives of Traditional Chinese Medicine, 2023, 41(4): 221-225. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202304046.htm
|
[3] |
HENRÍQUEZ S, KOHEN P, XU X, et al. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome[J]. Hum Reprod, 2020, 35(7): 1655-1665. doi: 10.1093/humrep/deaa098
|
[4] |
ZHOU Y P, GU B X, BRICHANT G, et al. The steroid hormone estriol (E3) regulates epigenetic programming of fetal mouse brain and reproductive tract[J]. BMC Biol, 2022, 20(1): 93. DOI: 10.1186/s12915-022-01293-4.
|
[5] |
谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018: 70-73.
XIE X, KONG B H, DUAN T. Obstetrics and gynecology[M]. 9th edition. Beijing: People ' s Medical Publishing House, 2018: 70-73.
|
[6] |
吴丹, 楼叶琳. 经阴道超声检测黄体及子宫螺旋动脉血流用于诊断早孕流产的临床价值[J]. 中华全科医学, 2021, 19(5): 830-832, 837. doi: 10.16766/j.cnki.issn.1674-4152.001928
WU D, LIU Y L. Clinical value of transvaginal ultrasonography in the diagnosis of abortion during early pregnancy[J]. Chinese Journal of General Practice, 2021, 19(5): 830-832, 837. doi: 10.16766/j.cnki.issn.1674-4152.001928
|
[7] |
TEBBENS M, HEIJBOER A C, T ' SJOEN G, et al. The role of estrone in feminizing hormone treatment[J]. J Clin Endocrinol Metab, 2022, 107(2): e458-e466. doi: 10.1210/clinem/dgab741
|
[8] |
GARGUS E S, BAE Y, CHEN J, et al. An ovarian steroid metabolomic pathway analysis in basal and polycystic ovary syndrome (PCOS)-like gonadotropin conditions reveals a hyperandrogenic phenotype measured by mass spectrometry[J]. Biomedicines, 2022, 10(7): 1646. DOI: 10.3390/biomedicines10071646.
|
[9] |
JI X Y, LI N, MA M, et al. Comparison of the mechanisms of estrogen disrupting effects between triphenyl phosphate (TPhP) and tris (1, 3-dichloro-2-propyl) phosphate (TDCIPP)[J]. Ecotoxicol Environ Saf, 2022, 229(9): 1130-1139.
|
[10] |
ALABIAD M A, SAID W M M, GAD A H, et al. Evaluation of different doses of the aromatase inhibitor letrozole for the treatment of ectopic pregnancy and its effect on villous trophoblastic tissue[J]. Reprod Sci, 2022, 29(10): 2983-2994. doi: 10.1007/s43032-022-00993-0
|
[11] |
ZHANG J, CHEN L, ZHENG C H, et al. Effect of Shoutai Pills on Th1/Th2 cytokines in serum and endometrium of rats with stimulated ovulation[J]. Curr Med Sci, 2019, 39(2): 285-290. doi: 10.1007/s11596-019-2032-4
|
[12] |
HE L G, ZHANG W J, YANG S Y, et al. Impact of genetic variants in IL-2RA and IL-2RB on breast cancer risk in Chinese Han women[J]. Biochem Genet, 2021, 59(3): 697-713. doi: 10.1007/s10528-021-10029-y
|
[13] |
TEJERA E, PÉREZ-CASTILLO Y, CHAMORRO A, et al. A multi-objective approach for drug repurposing in preeclampsia[J]. Molecules, 2021, 26(4): 63-70.
|
[14] |
RUSIDZÉ M, GARGAROS A, FÉBRISSY C, et al. Estrogen actions in placental vascular morphogenesis and spiral artery remodeling: a comparative view between humans and mice[J]. Cells, 2023, 12(4): 620. DOI: 10.3390/cells12040620.
|
[15] |
ZHANG S J, TANG Y, WANG X J, et al. Estrogen valerate pretreatment with the antagonist protocol does not increase oocyte retrieval in patients with low ovarian response: a randomized controlled trial[J]. Hum Reprod, 2022, 37(7): 1431-1439. doi: 10.1093/humrep/deac081
|
[16] |
GIBSON D A, ESNAL-ZUFIAURRE A, BAJO-SANTOS C, et al. Profiling the expression and function of oestrogen receptor isoform ER46 in human endometrial tissues and uterine natural killer cells[J]. Hum Reprod, 2020, 35(3): 641-651. doi: 10.1093/humrep/dez306
|
[17] |
HIROTA Y. Progesterone governs endometrial proliferation -differentiation switching and blastocyst implantation[J]. Endocr J, 2019, 66(3): 199-206. doi: 10.1507/endocrj.EJ18-0431
|